Navidea Biopharmaceuticals, Inc. announced execution of a Stock Purchase Agreement with an existing investor, John K. Scott, Jr., pursuant to which the Company will issue to the Investor in a private placement up to $3.0 million in shares of the Company’s common stock, par value $0.001 per share.
March 22, 2019
· 7 min read